Results
NATCO Pharma Q2 FY27 Net Profit at ₹203 Crore
Board approved Q2 FY27 unaudited consolidated financial results with ₹1,019 crore revenue and ₹203 crore profit.
Declared second interim dividend of ₹1.25 per share (62.50%) with record date 19-Nov-20